FOLH1 and posterior cortical atrophy: Several authors have shown higher disease free survival rates (64% vs. 34%), and lower long term requirement of ADT administration when using 68GA- PSMA PET vs. 18F-Choline for directed oligometastatic PCa treatment [95,96].